Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Androgen Deprivation as a Strategy for Prostate Cancer ChemopreventionJNCI : Journal of the National Cancer Institute, 1997-05, Vol.89 (10), p.689-696 [Peer Reviewed Journal]1997 INIST-CNRS ;ISSN: 0027-8874 ;EISSN: 1460-2105 ;DOI: 10.1093/jnci/89.10.689 ;PMID: 9168183Full text available |
|
2 |
Material Type: Article
|
Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline UpdateJournal of clinical oncology, 2018-07, Vol.36 (19), p.1994-2001 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2018.78.1914 ;PMID: 29620997Full text available |
|
3 |
Material Type: Article
|
Exercise, Diet, and Weight Management During Cancer Treatment: ASCO GuidelineJournal of clinical oncology, 2022-08, Vol.40 (22), p.2491-2507 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.22.00687 ;PMID: 35576506Full text available |
|
4 |
Material Type: Article
|
High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer typesAnnals of oncology, 2021-05, Vol.32 (5), p.661-672 [Peer Reviewed Journal]2021 The Authors ;Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2021.02.006 ;PMID: 33736924Full text available |
|
5 |
Material Type: Article
|
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working GroupAnnals of oncology, 2020-11, Vol.31 (11), p.1491-1505 [Peer Reviewed Journal]2020 European Society for Medical Oncology ;Copyright © 2020 European Society for Medical Oncology. All rights reserved. ;Attribution - NonCommercial ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2020.07.014 ;PMID: 32853681Full text available |
|
6 |
Material Type: Article
|
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized TrialJournal of clinical oncology, 2020-09, Vol.38 (25), p.2830-2838 [Peer Reviewed Journal]2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.20.00818 ;PMID: 32484754Full text available |
|
7 |
Material Type: Article
|
Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled TrialJournal of clinical oncology, 2021-04, Vol.39 (11), p.1234-1242 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.20.03282 ;PMID: 33497252Full text available |
|
8 |
Material Type: Article
|
Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA ProfilingCancer discovery, 2017-12, Vol.7 (12), p.1394-14032017 American Association for Cancer Research. ;ISSN: 2159-8274 ;EISSN: 2159-8290 ;DOI: 10.1158/2159-8290.cd-17-0716 ;PMID: 28899864Full text available |
|
9 |
Material Type: Article
|
Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of oncology, 2020-09, Vol.31 (9), p.1119-1134 [Peer Reviewed Journal]2020 European Society for Medical Oncology ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2020.06.011 ;PMID: 32593798Full text available |
|
10 |
Material Type: Article
|
Exosome-based liquid biopsies in cancer: opportunities and challengesAnnals of oncology, 2021-04, Vol.32 (4), p.466-477 [Peer Reviewed Journal]2021 The Author(s) ;Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2021.01.074 ;PMID: 33548389Full text available |
|
11 |
Material Type: Article
|
Validation of a Prediction Tool for Chemotherapy Toxicity in Older Adults With CancerJournal of clinical oncology, 2016-07, Vol.34 (20), p.2366-2371 [Peer Reviewed Journal]2016 by American Society of Clinical Oncology. ;2016 by American Society of Clinical Oncology 2016 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2015.65.4327 ;PMID: 27185838Full text available |
|
12 |
Material Type: Article
|
Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate CancerJournal of clinical oncology, 2016-07, Vol.34 (20), p.2325-2332 [Peer Reviewed Journal]2016 by American Society of Clinical Oncology. ;2016 by American Society of Clinical Oncology 2016 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2016.67.0448 ;PMID: 27044935Full text available |
|
13 |
Material Type: Article
|
Cancer statistics, 2023CA: a cancer journal for clinicians, 2023-01, Vol.73 (1), p.17-48 [Peer Reviewed Journal]2023 The Authors. CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society. ;Copyright Wiley Subscription Services, Inc. Jan/Feb 2023 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21763 ;PMID: 36633525Full text available |
|
14 |
Material Type: Article
|
Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II StudyJournal of clinical oncology, 2021-09, Vol.39 (27), p.2991-3001 [Peer Reviewed Journal]2021 by American Society of Clinical Oncology 2021 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.03555 ;PMID: 34292792Full text available |
|
15 |
Material Type: Article
|
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic SyndromesJournal of clinical oncology, 2021-04, Vol.39 (11), p.1223-1233 [Peer Reviewed Journal]2021 by American Society of Clinical Oncology 2021 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.20.01659 ;PMID: 33539200Full text available |
|
16 |
Material Type: Article
|
Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic MelanomaJournal of clinical oncology, 2021-08, Vol.39 (24), p.2656-2666 [Peer Reviewed Journal]2021 by American Society of Clinical Oncology 2021 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.21.00612 ;PMID: 33979178Full text available |
|
17 |
Material Type: Article
|
Foods and beverages and colorectal cancer risk: a systematic review and meta-analysis of cohort studies, an update of the evidence of the WCRF-AICR Continuous Update ProjectAnnals of oncology, 2017-08, Vol.28 (8), p.1788-1802 [Peer Reviewed Journal]2017 European Society for Medical Oncology ;The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdx171 ;PMID: 28407090Full text available |
|
18 |
Material Type: Article
|
Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and HeartJournal of thoracic oncology, 2015-09, Vol.10 (9), p.1240-1242 [Peer Reviewed Journal]2015 International Association for the Study of Lung Cancer ;Copyright © 2015 by the International Association for the Study of Lung Cancer ;ISSN: 1556-0864 ;EISSN: 1556-1380 ;DOI: 10.1097/JTO.0000000000000663 ;PMID: 26291007Full text available |
|
19 |
Material Type: Article
|
Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin LymphomaJournal of clinical oncology, 2017-07, Vol.35 (19), p.2125-2132 [Peer Reviewed Journal]2017 by American Society of Clinical Oncology 2017 American Society of Clinical Oncology ;ISSN: 0732-183X ;ISSN: 1527-7755 ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2016.72.1316 ;PMID: 28441111Full text available |
|
20 |
Material Type: Article
|
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer ConsortiumAnnals of oncology, 2021-06, Vol.32 (6), p.787-800 [Peer Reviewed Journal]2021 The Author(s) ;Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved. ;2021 The Author(s) 2021 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2021.02.024 ;PMID: 33746047Full text available |